Abnormal diastolic currents in ventricular myocytes from spontaneous hypertensive heart failure rats. Am J Physiol Heart Circ Physiol 291: H2192-H2198, 2006. First published June 9, 2006 doi:10.1152/ajpheart.01146.2005.-Hypertension is a common cause of heart failure, and ventricular arrhythmias are a major cause of death in heart failure. The spontaneous hypertension heart failure (SHHF) rat model was used to study altered ventricular electrophysiology in hypertension and heart failure. We hypothesized that a reduction in the inward rectifier K ϩ current (IK1) and expression of pacemaker current (If) would favor abnormal automaticity in the SHHF ventricle. SHHF ventricular myocytes were isolated at 2 and 8 mo of age and during end-stage heart failure (Ն17 mo); myocytes from age-matched rats served as controls. Inward IK1 was significantly reduced at both 8 and Ն17 mo in SHHF rats compared with controls. There was a reduction in inward IK1 due to aging in the controls only at Ն17 mo. We found a significant increase in If at all ages in the SHHF rats, compared with young controls. In controls, there was an age-dependent increase in If. Action potential recordings in the SHHF rats demonstrated abnormal automaticity, which was abolished by the addition of an If blocker (10 M zatebradine). Increased If during hypertension alone or combined increases in If with reduced IK1 during the progression to hypertensive heart failure contribute to a substrate for arrhythmogenesis. aging; pacemaker current; inward rectifier potassium current; abnormal automaticity HYPERTENSION CAN LEAD TO COMPENSATORY hypertrophy in cardiac muscle. Chronically, these compensatory mechanisms can become maladaptive, and cardiomyopathy and heart failure can result (22). Experimental animal studies in hypertrophy and heart failure have shown abnormalities in ion channel function, altered expression and function of proteins involved in excitation-contraction coupling, and an increased propensity for cardiac arrhythmias (16, 30, 32) . Clinically, ventricular arrhythmias occur in 80% of heart failure patients (11). However, the mechanisms of arrhythmogenic electrophysiological remodeling during hypertension and hypertensive heart failure are not fully elucidated.
HYPERTENSION CAN LEAD TO COMPENSATORY hypertrophy in cardiac muscle. Chronically, these compensatory mechanisms can become maladaptive, and cardiomyopathy and heart failure can result (22) . Experimental animal studies in hypertrophy and heart failure have shown abnormalities in ion channel function, altered expression and function of proteins involved in excitation-contraction coupling, and an increased propensity for cardiac arrhythmias (16, 30, 32) . Clinically, ventricular arrhythmias occur in 80% of heart failure patients (11) . However, the mechanisms of arrhythmogenic electrophysiological remodeling during hypertension and hypertensive heart failure are not fully elucidated.
Spontaneous hypertensive heart failure (SHHF) rats develop hypertension at an early age. In contrast to spontaneously hypertensive rats (SHRs), the SHHF rats consistently develop reproducible, hypertensive heart failure in an age-dependent manner (26) . Echocardiographic studies in the SHHF rat demonstrate left ventricular dysfunction (left ventricular ejection fraction Ͻ40%) at 17-18 mo of age (31) . There is also evidence of progressive cardiac hypertrophy in the SHHF rats, evidenced as an increase in heart weights (36) .
Hypertension and heart failure can increase the pacemaker current (I f ) in the ventricular myocardium (4 -7) . This can pathologically alter the diastolic phase of the action potential and enhance abnormal automaticity. In addition, aging has been shown to increase I f density in both normal and hypertensive (SHR) rat ventricles (5) .
Normally, the diastolic membrane potential is primarily regulated by the inward rectifier K ϩ current (I K1 ). I K1 is reduced in heart failure and, consequently, may contribute to increased excitability of the ventricle (30) . We hypothesized that chronic hypertension and the resultant heart failure would lead to altered diastolic membrane currents, providing a substrate for abnormal excitability and automaticity. We measured I K1 and I f in SHHF rats during the development of hypertension and heart failure in comparison to age-matched controls. Our observations suggest that changes in I K1 and I f provide a mechanism for the initiation of ventricular arrhythmias during hypertension, heart failure, and aging.
METHODS
SHHF rats were obtained from the colony produced by S. McCune at the Ohio State University (25) . Only phenotypically lean SHHF rats of either sex were used for this study. SHHF rats of either sex were studied at 2 and 8 mo of age and after the development of overt heart failure. As previously described, heart failure was identified between 16 and 22 mo of age and was defined as a left ventricular ejection fraction Ͻ40% by echocardiography, with signs of labored breathing, cyanosis, subcutaneous edema, piloerection, cold extremities (tails), and orthopnea (8, 26) . Age-matched Wistar-Furth or Wistar rats (Harlan, Indianapolis, IN) of either sex were used as controls (8, 31) .
Animals were deeply anesthetized with intraperitoneal injection of pentobarbital sodium, and the heart was rapidly removed. After the heart was flushed, it was weighed, and heart weight-to-body weight ratio was calculated. All animal procedures were approved by the Ohio State University Institutional Laboratory Animal Care and Use Committee.
Voltage-clamp recordings. Ventricular myocytes were isolated by using a previously described method (3). Myocytes were stored at room temperature under an oxygen hood until studied. Only cells with clear striations and sharp margins were studied. All data were acquired within 8 h of cell isolation to minimize potential time-dependent changes in the currents.
Cells were placed in a dish (Cell Microcontrols, Virginia Beach, VA) and superfused with test solutions; the bath temperature was maintained at 35°C with a temperature controller (Cell Microcontrols). Solutions were changed with a six-port gravity flow system (ϳ1 ml/min). Data acquisition was performed with pClamp software (version 8, Axon Instruments, Union City, CA) and an Axopatch 200A patch-clamp amplifier (Axon Instruments).
The amphotericin B-perforated, whole cell, patch-clamp technique was used for all recordings to minimize alterations in the intracellular milieu. Patch pipettes (2-5 M⍀) were used, and after seal formation, changes in the capacitative response to a Ϫ10-mV step were used to monitor perforation of the patch by amphotericin B. Series resistance compensation was applied (40 -60%) to minimize voltage errors. Only cells with low access resistance (Ͻ20 M⍀) that was stable (Ͻ20% change in series resistance) were included in the data analysis.
The bath solution contained (in mM) 134 NaCl, A holding potential of Ϫ40 mV was used for all voltage-clamp experiments to inactivate sodium current. A series of 100-ms test potentials from Ϫ140 to ϩ40 mV, with a 20-mV increment, were used to elicit IK1. The current was measured at the end of each 100-ms test potential. I K1 was defined as barium-sensitive current and was measured as the difference in current between that in the control solution and that in the bath solution with 2 mM BaCl 2. If was measured after the addition of BaCl 2 to the bath solution. If was elicited by using 1-s voltage steps from Ϫ130 to Ϫ50 mV applied at 5-s intervals. If was measured as the difference between the instantaneous inward current and that at the end of each voltage step.
Action potentials. In separate experiments, we used current-clamp recordings to evaluate resting potential and abnormal automaticity. For these recordings, the bath solution contained (in mM) 134 NaCl, 1 MgCl 2, 5 KCl, 5 HEPES, 1.8 CaCl2, and 5 D-glucose; pH was adjusted to 7.40 with NaOH. Cells were stimulated at 0.2, 0.5, 1, and/or 2 Hz. The proportion of myocytes exhibiting abnormal automaticity was calculated. Zatebradine (10 M) was used as an I f blocker (12, 39) .
Reagents. Zatebradine was supplied by Boehringer Ingleheim Pharma. All other reagents were purchased from Sigma Chemical (St. Louis, MO).
Data analysis. Cardiac hypertrophy was assessed by the heart weight-to-body weight ratio [heart wt (in mg)/body wt (in g)] (37). The measured currents were expressed as current density (in pA/pF) after normalization for cell capacitance. IK1 inward conductance (in mS/cm 2 ) was determined by calculating the slope of the linear portion of the current density-voltage relationship from Ϫ140 mV to Ϫ100 mV (3). Peak outward IK1 density was measured at Ϫ60 mV (IϪ60). The I K1 rectification ratio was calculated as {[(IϪ100) Ϫ (IϪ60)]/ I Ϫ100} ϫ 100 (2, 24) .
In pilot experiments, we constructed a threshold (ϾϪ0.60 pA/pF) for identification of If by identifying a value that included 95% of the end-stage heart failure myocytes while excluding 90% of the 2-moold control myocytes. To assess the physiological relevance of I f, only cells classified as having significant I f were included in the analysis of current differences at Ϫ90 mV.
If current density (in pA) was normalized to the cell capacitance (in pF) and expressed as pA/pF. All data were included for the currentvoltage and current density-voltage relationship analyses.
Initial statistical analysis revealed no sex-dependent statistical differences; male and female data were pooled for further analyses. Two-way ANOVA with post hoc Student-Newman-Keuls test was used to test for differences between groups. One-way ANOVA was used to test for age-dependent cardiac hypertrophy in the SHHF rats. Differences in the proportion of cells demonstrating If (as defined above) were assessed by using the Pearson 2 -square test. Data are presented as means Ϯ SE. Statistical significance was defined as P Ͻ 0.05. Statistical analysis was performed using SAS for Windows (version 8.0.1; SAS Systems, Cary, NC).
RESULTS
The heart weight-to-body weight ratio was increased in the SHHF rats compared with controls at both 2 mo (7.2 Ϯ 0.9 vs. 4.3 Ϯ 0.2 in SHHF rats and controls, respectively, P Ͻ 0.05) and Ն17 mo (10.6 Ϯ 1.6 vs. 3.2 Ϯ 0.2 in SHHF rats and controls, respectively, P Ͻ 0.02). In controls, significant myocyte hypertrophy only occurred in the oldest group (Fig. 1) .
Inward rectifier I K1 . Representative barium-sensitive current tracings and mean data from SHHF and control myocytes are shown in Fig. 2 . In contrast to controls, in SHHF myocytes, there was a decrement in inward I K1 conductance at 8 mo, which was decreased further after the onset of heart failure (P Ͻ 0.05). Notably, even in control myocytes, there was a reduction in inward I K1 conductance at an advanced age; however, inward I K1 conductance in controls was still substantially larger compared with the age-matched SHHF rats (P Ͻ 0.05).
Analysis of peak outward I K1 showed no age-dependent change in the controls. The SHHF rats showed a substantial reduction in peak outward I K1 , but only during heart failure. The rectification ratio was decreased in an age-dependent manner in controls, consistent with reduced rectification of the current as a function of "normal" aging. In the SHHF rats, there was a significantly larger reduction in the rectification ratio at the oldest age compared with age-matched controls, consistent with a further decrement in current rectification with heart failure. In summary, normal aging, hypertension and hypertrophy, and heart failure all appeared to reduce the I K1 rectification ratio.
I f . Figure 3 depicts barium-insensitive current recordings (A and B) and summary data for ventricular I f in Wistar-Furth and SHHF rats in all myocytes tested (C and D). There was an age-dependent increase in I f in Wistar-Furth rats. In SHHF rats, the I f was larger at all ages compared with 2-mo-old controls. There were no age-or heart failure-dependent increases in I f density in the SHHF groups. When only cells expressing significant I f (as defined in METHODS) were analyzed (Fig. 3, E and F) , there were significantly more myocytes expressing I f in the SHHF groups at both 2 and 8 mo of age. However, at Ն17 mo of age, there was no difference between control and SHHF rats in the proportion of myocytes expressing I f . The amplitude of I f increases as a function of myocyte size (Fig. 3F , P Ͻ 0.035). Fig. 1 . Cell capacitance as a function of rat strain and age. There is an increase in myocyte size in Wistar-Furth (WF) controls. Myocyte size is larger in spontaneous hypertensive heart failure (SHHF) rats than in controls at 8 and Ն17 mo of age. *P Ͻ 0.05 compared with 2-mo-old WF rats; †P Ͻ 0.05 compared with 8-mo-old WF rats; ‡P Ͻ 0.05 compared with 2-mo-old SHHF rats; §P Ͻ 0.05 compared with Ն17-mo-old WF rats.
Physiological impact of altered diastolic currents: abnormal automaticity. To evaluate the role of I f at physiological resting membrane potentials, we conducted an additional analysis at a test potential of Ϫ90 mV. There was a significant difference between groups at 2 mo of age (Ϫ0.06 Ϯ 0.04 vs. Ϫ0.27 Ϯ 0.36 pA/pF in control and SHHF rats, respectively). At 8 and Ն17 mo of age, there was no significant difference between groups in the I f at Ϫ90 mV.
We recorded action potentials from 2-mo-old (10 cells) and 8-mo-old (3 cells) SHHF rats. Action potentials were recorded in 11 myocytes from 2-to 6-mo-old Wistar rats; no agedependent differences in action potential characteristics were found in the Wistar myocytes, and these data were pooled (resting membrane potential of Ϫ81.2 Ϯ 2.6 and Ϫ82.4 Ϯ 1.7 mV at 2 and 6 mo, respectively). There was no difference between 2-mo-old SHHF myocytes and control myocytes in the resting membrane potential. The resting membrane potential was reduced in the 8-mo-old SHHF myocytes compared with Wistar controls (P Ͻ 0.05). There was an age-dependent reduction in resting membrane potential in myocytes from the SHHF rats, because the 8-mo-old SHHF myocytes (where I K1 was reduced) were depolarized compared with 2-mo-old SHHF myocytes (Ϫ72.2 Ϯ 1.8 vs. Ϫ80.6 Ϯ 1.2 mV, respectively; P Ͻ 0.05).
In control myocytes, we did not observe any evidence of abnormal automaticity (0 of 11). In contrast, in the 2-mo-old SHHF myocytes, we observed abnormal automaticity in three of five myocytes at 0.2 Hz. At a faster stimulation rate of 0.5 Hz, none of the myocytes (zero of 8) from the 2-mo-old SHHF rats exhibited abnormal automaticity; in contrast, two out of three myocytes from the 8-mo-old SHHF rats exhibited abnormal automaticity at 0.5 Hz. Abnormal automaticity was abolished by zatebradine (I f channel blocker) and reappeared after washout of zatebradine (Fig. 4) . At stimulation rates of 1 and 2 Hz, no abnormal automaticity (0/13) was evident in the SHHF myocytes.
DISCUSSION
There is an increased prevalence of ventricular arrhythmias (premature ventricular depolarizations and nonsustained ventricular tachycardia) observed during aging in healthy humans ϩ current (IK1) is altered by age in controls and by progression to heart failure in SHHF rats. A: barium-sensitive current density recordings from 2-mo-old (left) and 17-mo-old (right) WF rats. B: representative barium-sensitive current density recorded from 2-mo-old (left) and Ͼ17-mo-old (right) SHHF myocytes. In A and B, arrows indicate zero current. C: current density-voltage relationships of WF and SHHF myocytes. (ᮀ, 2-mo-old WF rats; E, 8-mo-old WF rats; ‚, 17-mo-old WF rats; ■, 2-mo-old SHHF rats; F, 8-mo-old SHHF rats; OE, Ͼ17-mo-old SHHF rats). D: normalized inward IK1 conductance for WF (open bars) and SHHF (solid bars) rats at different ages. Numbers on each bar indicate total cells in each group. E: peak outward current at Ϫ60 mV as a function of strain at different ages. F: rectification ratio for WF and SHHF rats (*age-dependent change from 2-mo-old WF rats; †different from 8-mo-old WF rats; ‡age-dependent change from 2-mo-old SHHF rats; §different from 8-mo-old SHHF rats; #different from 17-mo-old WF rats; P Ͻ 0.05). (10, 18, 21) . The frequency and complexity of ventricular arrhythmias are increased in hypertensive patients, even in the absence of left ventricular hypertrophy (9) . The presence of left ventricular hypertrophy in hypertensive patients results in increased complexity and frequency of ventricular arrhythmias, including sudden cardiac death (1, 34, 35) . Interpretation of studies evaluating arrhythmias in patients with hypertensive left ventricular hypertrophy is potentially confounded by the use of pharmacotherapy with the potential to cause electrolyte imbalances, and thus, result in increased arrhythmia risk. During heart failure, ventricular arrhythmias occur in ϳ80% of patients (11) , and many with heart failure die of sudden cardiac death. We used the SHHF rat model and age-matched controls to evaluate the ventricular diastolic membrane currents, I K1 and I f , and found differential regulation of these currents by hypertension, heart failure, and aging. SHHF rats are a reliable model for human hypertension and heart failure. Systolic blood pressures are consistently elevated in the SHHF rats but are decreased after the progression to significant heart failure (which typically occurs in phenotypically lean SHHF rats at 15-30 mo of age) (15, 26) . Myocyte size is increased as early as 2 mo of age in SHHF rats, and progressive myocyte and cardiac hypertrophy have been reported through 12 mo of age in the SHHF rats (28) . During heart failure, the SHHF rats have intracardiac thrombi, myocyte hypertrophy, and increased cardiac interstitial fibrosis (17) .
Wistar and Wistar-Furth rats have been used as a suitable control for SHHF rats (8) . Wistar-Furth rats have normal blood pressures during early to middle adult ages (14) , although, recently, the systolic blood pressure in aged Wistar-Furth rats (21 mo old) was reported to be elevated, ϳ160 mmHg (38) . Thus it is possible that hypertension may have contributed to the increased myocyte capacitance and increased I f in the aged controls.
We observed an age-dependent decrement in I K1 in the control group. This is in contrast to previous reports where no change in I K1 was reported when comparing ventricular myocytes from 3-and 9-mo-old (20) or young and senescent (24-to 25-mo-old) Wistar rats (40) . Although we did observe a reduction in the aged control rats, there was a significantly greater reduction in I K1 with age and disease progression in Fig. 3 . Pacemaker current (If) is altered by age in controls and by hypertension and heart failure in SHHF rats. A: barium-insensitive current density recordings from 2-mo-old WF myocyte (left) and 17-mo-old WF rat (right). B: bariuminsensitive current density recorded from 2-mo-old SHHF rats (left) and end-stage SHHF rats (right). Dashed lines in A and B indicate zero current. C and D: current-voltage curves for WF and SHHF rats, respectively, at different ages (ᮀ, 2-mo-old WF rats; E, 8-mo-old WF rats; ‚, Ն17-mo-old WF rats; ■, 2-mo-old SHHF rats; F, 8-mo-old SHHF rats; OE, Ն17-mo-old SHHF rats). *P Ͻ 0.05 for current densityvoltage relationship compared with that in 2-mo-old WF controls. E: percentage of myocytes in C and D expressing significant If in each group. *P Ͻ 0.05 compared with age-matched controls. F: relationship between cell size and If amplitude in control (ᮀ) and SHHF (■) myocytes. Current amplitude increases as cellular hypertrophy develops (r 2 ϭ 0.74 and P Ͻ 0.035).
SHHF rats. When compared with SHHF rats, the age-matched Wistar-Furth rats expressed a statistically decreased inward conductance only in the Ն17-mo age group. To our knowledge, this decrease in inward I K1 during aging has not been previously reported and could contribute to a depolarized diastolic membrane potential. The peak outward I K1 was significantly altered only in end-stage SHHF rats, consistent with a heart failure-induced response. This reduction would be expected to result in a prolongation of terminal repolarization and has been previously described in other heart failure models (16, 32) . We observed a significant reduction in the I K1 rectification ratio with age in both controls and SHHF rats. The rectification ratio decrease was more pronounced in SHHF rats than in Wistar-Furth rats. Rectification of I K1 is modulated by testosterone, intracellular magnesium, and intracellular polyamines; (2, 23, 27) alterations in these regulators have been reported during aging, hypertension and heart failure, (13, 19, 29, 33) and may be the basis of this observation.
In normal human and rat hearts, there is a low level of ventricular I f , and the proportion of cells with significant I f is less in controls, when compared with myocytes from failing hearts (5, 7). Ventricular I f is increased in both amplitude and prevalence with both normal aging and hypertension in rats (4, 5) . The age-dependent increase we observed in the proportion of myocytes expressing I f in controls is similar to that reported in normal Wistar-Kyoto rats (5) . Notably, the age dependence of the proportion of myocytes we observed with I f in the SHHF rats differs from that previously reported in SHRs, where the occurrence of I f in young SHRs did not differ from that in young controls (5) . The reason for this difference is unclear; it is interesting to note that, whereas both SHRs and SHHF rats are hypertensive at a young age, only SHHF rats consistently progress to develop heart failure at an early age.
Similar to the observed increases in I f in both control and SHHF rats, ventricular I f is increased in human myocytes as a result of normal aging, hypertension, and heart failure (6, 7). We found that the amplitude of I f was positively correlated with cell size, and this suggests that hypertrophy, and not heart failure per se, increases I f , consistent with a previous report in hypertensive rats (4) . This relationship explains why we did not observe a further increase in current density with progressive heart failure in the SHHF rats, as there was no further increase in myocyte capacitance (Fig. 1) .
The early occurrence of I f in the SHHF rats is consistent with the known response to hypertension (5). Thus our data suggest that hypertension can mediate increased I f even at an early age in the SHHF rat. Progression from hypertension to hypertensive heart failure increases I f amplitude, but not current density, because amplitude is tightly correlated with myocyte size. This differs from a previous report by Cerbai et al. (5) in SHRs where cell size did not correlate with I f amplitude, although they did observe a significant correlation in controls.
The physiological relevance of the I f expression in the SHHF rats can be evaluated by comparing the current at Ϫ90 mV (to approximate a normal resting potential). This reveals a significant increase in current amplitude as a function of age in both control and SHHF rats, although the current was always larger in the SHHF rats.
I f is a time-dependent current, so we used variable action potential stimulation rates to assess the physiological impact of I f . Our data indicate that increased I f alone (as observed in the 2-mo-old SHHF rats) is sufficient to result in abnormal automaticity, only at very low stimulation rates (0.2 Hz). On the basis of the data from both 2-and 8-mo-old SHHF myocytes, both an increase in I f and a reduction in inward I K1 are necessary for abnormal automaticity to occur at a faster stimulation rate (0.5 vs. 0.2 Hz). Our data suggest that altered excitability through a combination of decreases in I K1 and increases in I f could precipitate arrhythmias during aging, hypertension, and heart failure.
Limitations. We did not directly measure blood pressure in our cohort of animals. However, the SHHF rats have reproducible blood pressures at the time points used in this study, which we obtained from the literature. The SHHF rats in this study were phenotypically lean, a mixture of animals heterozygous for or lacking the cp (corpulent) gene. This factor, and the use of both males and females, resulted in a more variable onset of heart failure than would be seen in genotypically lean rats of one sex. To control for this variable, we used echocardiography to define the presence of heart failure, using previously established criteria (8, 28). In conclusion, by using young adult and aged SHHF rats and control rats, we found that aging, hypertension, and heart failure have variable effects on diastolic membrane currents. Reductions in I K1 and increases in I f are both arrhythmogenic, and the magnitude of these changes is affected by age, hypertension, and heart failure. The finding of reduced I K1 in aged controls is interesting, as there are increased ventricular arrhythmias during normal aging in humans (10, 18) . Our results indicate that the underlying cause of arrhythmias may vary during the progression from hypertension to heart failure. I K1 is functionally regulated by testosterone, intracellular magnesium, and intracellular polyamines, whereas I f is regulated by the autonomic nervous system. This suggests that therapeutic interventions targeting each of these ionic currents may be required to minimize ventricular arrhythmias during the progression of hypertensive heart failure.
